Detection of carbapenem resistance in ESBL-positive and carbapenemase-producing Klebsiella pneumoniae strains using phenotypic and molecular methods
- 1 July 2026
- journal article
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 17 (7) , 676-680
Abstract
Aim Antimicrobial resistance is a major global and national health concern. Carbapenem-resistant Klebsiella pneumoniae (CRKP) ranks at the top of the WHO 2024 list. K. pneumoniae causes significant morbidity and mortality among ICU patients. This study aimed to detect carbapenemase enzymes (KPC, NDM, OXA-48, and VIM) in carbapenem-resistant and ESBL-positive K. pneumoniae strains isolated from respiratory and blood samples using PCR. Methods Samples from 75 ICU patients hospitalized at Cerrahpaşa Medical Faculty Hospital in 2023 were analyzed. Respiratory tract (BAL, ETA, sputum) and blood cultures were processed using conventional methods (Blood agar, Chromoagar, MIO medium) and automated systems (Vitek 2 Compact, MALDI-TOF). Isolates were stored at -80 °C, subcultured, and subjected to DNA extraction. Carbapenemase genes (KPC, NDM, OXA-48, VIM) were identified by Real-Time PCR. Results Of the 75 patients, 62.7% were male, with a mean age of 62.6 ± 18.3 years. Respiratory tract samples comprised 56%, and blood cultures 44%. Resistance rates were 52% for imipenem and 90.7% for meropenem. Gene prevalence was NDM 92%, OXA-48 84%, KPC 81.3%, and VIM 78.7%. Coexistence patterns included KPC + OXA-48 + NDM + VIM (70.7%) and OXA–48 + NDM (8%). No carbapenemase genes were detected in 5.3% of isolates. No significant differences were found by gender, age, or ICU type (p>0.05). Conclusion ICU infections caused by carbapenemase-producing K. pneumoniae pose a serious risk. Regular surveillance of carbapenemase-producing bacteria is crucial for infection control and antimicrobial stewardship.Keywords
This publication has 20 references indexed in Scilit:
- Global antibiotic resistance surveillance report 20252025
- News Brief: WHO releases 2024 Bacterial Priority Pathogens List.AJN, American Journal of Nursing, 2024
- Investigation of the prevalence of carbapenem resistance genes in faecal carriage of carbapenem resistant Klebsiella spp. isolates by multiplex real-time PCR methodThe Journal of Infection in Developing Countries, 2023
- Phenotypic and Genotypic Identification of Carbapenem-Resistant Klebsiella Pneumoniae and Determination of Antibiotic SusceptibilitySelcuk Tip Dergisi, 2023
- Molecular characterization of carbapenemase producing Klebsiella pneumoniae strains by multiplex PCR and PFGE methods: The first K.pneumoniae isolates co-producing OXA-48/KPC and KPC/NDM in TurkeyJournal of Infection and Chemotherapy, 2022
- Prophylaxis and Treatment against Klebsiella pneumoniae: Current Insights on This Emerging Anti-Microbial Resistant Global ThreatInternational Journal of Molecular Sciences, 2021
- Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative BacteriaClinical Infectious Diseases, 2019
- Carbapenem Resistance: A ReviewMedical Sciences, 2017
- The evaluation of antibiotic resistance status of Klebsiella pneumoniaeOrtadoğu Tıp Dergisi, 2017
- Use of chromogenic Agar in detection of urinary tract pathogens and antimicrobial SusceptibilityJournal of the Faculty of Medicine Baghdad, 2009